This inventor holds 3 USPTO granted patents. Top assignees: Amgen Research (Munich) Gmbh, Micromet Ag. Active years: 2011-2014.
Location History:
- München, DE (2011)
- Munich, DE (2012 - 2014)
Company Filing History:
Years Active: 2011-2014
Title: Carsten Reinhardt: Innovator in Cancer Treatment
Introduction
Carsten Reinhardt is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical research, particularly in the treatment of metastatic breast cancer. With a total of 3 patents to his name, Reinhardt's work has the potential to impact the lives of many patients.
Latest Patents
Reinhardt's latest patents focus on the use of an anti-EpCAM antibody for the manufacture of a medicament aimed at treating metastatic breast cancer. The invention outlines a method of administering this antibody to effectively treat the disease. This innovative approach highlights his commitment to advancing cancer treatment options.
Career Highlights
Throughout his career, Carsten Reinhardt has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Amgen Research GmbH and Micromet AG. His experience in these organizations has contributed to his expertise in developing groundbreaking medical solutions.
Collaborations
Reinhardt has collaborated with various professionals in his field, including his coworker Robert Saller. These partnerships have fostered an environment of innovation and shared knowledge, further enhancing the impact of their work.
Conclusion
Carsten Reinhardt's contributions to cancer treatment through his patents and collaborations demonstrate his dedication to improving patient outcomes. His innovative approaches continue to pave the way for advancements in medical research.